Voyager Therapeutics (VYGR) Revenue Growth (1y) (2016 - 2026)
Voyager Therapeutics (VYGR) Revenue Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Voyager Therapeutics | 183.25 Mn | 41.77 Mn | - | -59.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.94% |
| Dec 31, 2025 | 143.99% |
| Sep 30, 2025 | -45.73% |
| Jun 30, 2025 | -82.42% |
| Mar 31, 2025 | -66.81% |
| Dec 31, 2024 | -93.01% |
| Sep 30, 2024 | 433.79% |
| Jun 30, 2024 | 503.63% |
| Mar 31, 2024 | -87.04% |
| Dec 31, 2023 | 5,913.42% |
| Sep 30, 2023 | -88.77% |
| Jun 30, 2023 | 588.20% |
| Mar 31, 2023 | 22,769.30% |
| Dec 31, 2022 | -105.52% |
| Sep 30, 2022 | 2,672.33% |
| Jun 30, 2022 | -47.53% |
| Mar 31, 2022 | -89.88% |
| Dec 31, 2021 | 329.45% |
| Sep 30, 2021 | -98.74% |
| Jun 30, 2021 | -95.27% |